Healthcare, pharmaceutical, and life sciences legal services represent one of the key and core practice areas of Liu He Law Firm. The Healthcare, Pharmaceutical and Life Sciences of Liu He Law Firm comprises a professional team of lawyers with backgrounds in pharmaceutical disciplines and the pharmaceutical industry, possessing a deep understanding of the operational rules and developmental trends of the pharmaceutical sector. Team members graduated from top domestic and international universities with degrees in law, pharmacy, medicine, or related fields; multiple lawyers hold dual academic qualifications combining legal studies with pharmacy, medicine, or other disciplines; and some lawyers have previously served at multinational pharmaceutical corporations, well-known domestic listed pharmaceutical companies, the Big Four accounting firms, the National Intellectual Property Administration, and hospitals, enabling them to accurately grasp the regulatory dynamics and commercial logic of the pharmaceutical industry.
Liu He's lawyers are committed to providing clients in the pharmaceutical industry with one-stop, comprehensive, and high-quality legal services, guided by a thorough, pragmatic, professional, and innovative spirit. The Practice Group's client base encompasses multinational pharmaceutical companies, domestic pharmaceutical enterprises, medical device companies, biotechnology enterprises, healthcare institutions, contract research organisations (CROs), industry investment funds, and related natural persons. Services cover the full life cycle of pharmaceuticals, medical devices, healthcare institutions, and biotechnology enterprises, spanning the research and development, registration, manufacturing, commercialisation, and post-market supervision stages.
Liu He Law Firm provides comprehensive standing legal counsel services to pharmaceutical enterprises, covering all aspects of day-to-day operations: drafting and reviewing contracts and other legal documents; participating in the deliberation of major corporate decisions and providing legal opinions; assisting in negotiating with business partners and executing cooperation agreements; assisting in the formulation, review, and revision of internal rules and regulations, including but not limited to intellectual property (including patent and IP) protection policies, pharmaceutical industry compliance policies, and labour and human resources policies; conducting legal knowledge training for employees and inviting them to attend various legal practice forums organised by Liu He; providing specialist legal alerts on the latest laws and regulations, pharmaceutical industry policies, and changes in judicial practice relating to the pharmaceutical industry; and providing legal advisory opinions on the company's equity structure, organisational arrangements, and internal governance.
Liu He Law Firm has extensive experience and comprehensive service capabilities in investment, financing, M&A, and restructurings in the pharmaceutical industry, covering: equity, property rights, and interests investment, financing, and M&A for pharmaceutical enterprises; business development (BD) transactions, technology transfers, and regulatory approval transfers for pharmaceutical products; the establishment, fundraising, liquidation and dissolution, and day-to-day management of private equity and venture capital funds investing in the pharmaceutical sector, as well as their due diligence, investment, M&A, and exit activities; and the restructuring, corporatisation, and reorganisation of state-owned enterprises and institutions, as well as non-profit organisations.
Liu He's lawyers assist pharmaceutical enterprises in constructing and reviewing compliance systems covering the full life cycle of pharmaceutical research and development, manufacturing, sales and marketing, and third-party management. Services encompass industry access and regulation, academic activities, healthcare professional interactions, digital marketing, online pharmaceutical sales, cross-border pharmaceutical e-commerce, and other operational areas.
• Compliance System Construction: including contract management policies, anti-corruption management policies, product promotion and anti-commercial bribery management policies, intellectual property management policies, human resources management policies, anti-monopoly management policies, centralised procurement management policies, data compliance management policies, financial and tax management policies, product quality management policies, adverse event management policies, product R&D management policies, and supplier management policies.
• Compliance Training: providing customised compliance training for management and employees of pharmaceutical enterprises.
• Compliance Investigations: representing pharmaceutical enterprises in responding to criminal and administrative enforcement actions by government authorities, such as anti-monopoly investigations; collaborating with overseas lawyers to respond to corruption and bribery investigations by foreign regulatory authorities; and providing anti-commercial bribery internal investigations, compliance reviews of business partners, and other investigative legal services.
Liu He's lawyers provide services including pre-IPO restructuring and reorganisation, pre-IPO private financing, listed company governance, day-to-day capital markets legal services for listed companies, domestic initial public offerings and listings, overseas initial public offerings and listings, listed company acquisitions, reverse mergers, listed company refinancing, and major asset restructurings of listed companies.
Liu He's lawyers provide legal advisory services relating to the regulation of pharmaceutical products and medical devices, including product R&D and clinical trial compliance, product registration, product manufacturing, sales, packaging, and marketing, adverse drug reactions, product recalls, tendering and procurement, anti-monopoly matters, price controls, and healthcare insurance policies.
Liu He's lawyers provide comprehensive, professional, and innovative services to pharmaceutical companies, including pharmaceutical listings, drug development, patent portfolio management, technology transfer, cooperation, development, licensing, and intellectual property dispute resolution.
Liu He's lawyers represent clients in the pharmaceutical industry in handling related disputes, including BD transaction disputes, pharmaceutical investment and financing disputes, distribution agreement disputes, clinical trial disputes, medical damage compensation claims, monopoly and unfair competition disputes, and others.
Zhejiang Provincial People's Government, Zhejiang Provincial Market Supervision Administration, Zhejiang Provincial Medical Products Administration, Zhejiang Provincial Medical Security Bureau, Hangzhou Municipal Medical Security Bureau, and others.
Zhejiang University, Westlake University, Zhijiang Laboratory, National Key Laboratory for Structural Chemistry of Unstable and Stable Species (Wenzhou Institute for Advanced Study / Wenzhou Institute of Biomaterials and Engineering), Zhejiang Pharmaceutical Society, Zhejiang Pharmaceutical Industry Association, Zhejiang Medical Device Testing and Research Institute, Zhejiang Food and Drug Testing and Research Institute, Hangzhou Medical College, Zhejiang Provincial Blood Center, Hangzhou Xiaoshan District Medical Emergency Command Centre, Taizhou Jiaojiang District Qizhen Synthetic Biology Technology Research Institute, and Zhejiang University of Traditional Chinese Medicine (Quzhou Qujiang) Research Institute Co., Ltd., among others.
Zhejiang Medicines & Health Products Co., Ltd. (600216.SH), Zhejiang Jiuzhou Pharmaceutical Co., Ltd. (603456.SH), Zhejiang Huahai Pharmaceutical Co., Ltd. (600521.SH), Jiangsu Nhwa Pharmaceutical Co., Ltd. (688076.SH), Jiangxi Zhenshi Pharmaceutical Co., Ltd., Hangzhou Jitai Pharmaceutical Technology Co., Ltd. (an AI pharmaceutical unicorn enterprise), Zhejiang Xinma Biopharmaceutical Co., Ltd., Minghui Pharmaceutical (Hangzhou) Co., Ltd., Zhejiang Haichang Biopharmaceutical Co., Ltd., Zhejiang Jingyuetang Pharmaceutical Co., Ltd. (traditional Chinese medicine), Hangzhou Xiling Biotechnology Co., Ltd., Renhe (Group) Development Co., Ltd., Zhejiang Qizhen Synthetic Biology Technology Co., Ltd., and others.
Zhejiang Heze Pharmaceutical Technology Co., Ltd., Zhejiang Qianliyan Pharmaceutical Technology Co., Ltd., Hongrui (Hangzhou) Biopharmaceutical Co., Ltd., Zhejiang Haige Tang Pharmaceutical Co., Ltd., Hangzhou Lianhe Health Technology Co., Ltd., and others.
Zhejiang Province Zhencheng Pharmaceutical Technology Co., Ltd., Zhejiang Shengyu Medical Technology Co., Ltd., Zhejiang Da Conglin Pharmacy Chain Co., Ltd., Zhejiang Zhengjingyuan Da Pharmacy Chain Co., Ltd., and others.
Zhejiang Kehui Medical Equipment Co., Ltd., Zhejiang Lanhe Medical Supplies Co., Ltd., Hangzhou Wanlin Medical Equipment Co., Ltd., Shanghai Lange Medical Equipment Co., Ltd., Zhejiang Baol'man Biotechnology Co., Ltd., Hangzhou Weicheng Medical Technology Co., Ltd., Zhejiang Puke Medical Technology Co., Ltd., Shanghai Honghang Medical Equipment Co., Ltd., and others.
Dian Diagnostics Group Co., Ltd. (300244.SZ), Westlake Vitai (Hangzhou) Diagnostic Technology Co., Ltd., Hangzhou Tingke Biotechnology Co., Ltd., and others.
The First Affiliated Hospital of Zhejiang University School of Medicine, People's Armed Police Force Coast Guard Corps Hospital, Hangzhou Xiaoshan District Medical Emergency Command Centre, Taizhou Cancer Hospital, Huangyan Zhangzaidi Orthopedic Hospital, Hangzhou Zheng'ai Medical Cosmetology Clinic Co., Ltd., Xiangshan Jiabo Dental Hospital Co., Ltd., Xiangshan Rentai Traditional Chinese Medicine Comprehensive Clinic Co., Ltd., and Kangdafu Health Management (Zhejiang) Co., Ltd.
Paradise Silicon Valley Asset Management Group Co., Ltd., Hangzhou Heda High-Tech Development Group Co., Ltd., Zhejiang Da Conglin Investment Management Co., Ltd., Zhejiang Kangdele Hospital Investment Management Co., Ltd., and New Advance Pharmaceutical International Holdings Co., Ltd.
Hangzhou Yikefu Technology Co., Ltd., Zhejiang Hongjiaban Health Industry Co., Ltd., and Ningbo Yifan Pharmaceutical Technology Co., Ltd.
Hangzhou Yuxianghu Health Industry Management Co., Ltd., Zhongda Jinshi Langhe (Hangzhou) Nursing Home Co., Ltd., and Hangzhou Langhe Senior Care Services Co., Ltd.
The Healthcare, Pharmaceutical and Life Sciences is composed of multiple senior lawyers who combine pharmaceutical expertise with experience in serving large group companies. Deeply rooted in the pharmaceutical and healthcare sector, the team brings profound specialist knowledge and extensive practical experience, and is committed to building a comprehensive full-industry-chain legal service platform for healthcare institutions and pharmaceutical enterprises.
